US-Doppler and Procoagulant Microparticles for the Diagnosis of Asymptomatic DVT in Advanced Cancer Patients With Poor Performance Status
1 other identifier
observational
100
1 country
1
Brief Summary
The aim of this study is to determine the prevalence of asymptomatic lower extremity DVT detected by US-Doppler and procoagulant microparticles in a selected group of cancer patients suffering from an advanced stage of the disease. An attempt will be made to determine whether there is a correlation between this prevalence and various clinical and laboratory parameters.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2006
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2006
CompletedFirst Submitted
Initial submission to the registry
June 12, 2006
CompletedFirst Posted
Study publicly available on registry
June 13, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2010
CompletedDecember 14, 2010
April 1, 2007
4.5 years
June 12, 2006
December 13, 2010
Conditions
Keywords
Eligibility Criteria
patients with an advanced stage of the disease, hospitalized in the oncology department.
You may qualify if:
- Cancer patients with an advanced stage of the disease, hospitalized in the oncology department.
- WHO performance status of 3( i.e. spends more than half his/her time in bed or seated) - or 4 ( i.e. completely confined to bed or to chair) : for at least a week; according to the treating physician, the poor performance status results from advanced malignancy.
- Patient is asymptomatic for lower extremity DVT according to the treating physician
You may not qualify if:
- major surgery during more than a month, from the time of investigation
- anticoagulant therapy for more than one month, from the time of investigation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rambam medical center
Haifa, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nira Beck-Razi
Ministry of Health, Israel
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
June 12, 2006
First Posted
June 13, 2006
Study Start
June 1, 2006
Primary Completion
December 1, 2010
Study Completion
December 1, 2010
Last Updated
December 14, 2010
Record last verified: 2007-04